Drug database vendor Elsevier/Gold Standard will market a new standard for drug pricing that is touted as more accurately tracking true drug acquisition costs.

The company will be the exclusive distributor of Predictive Acquisition Cost pricing from Glass Box Analytics. The current standard for pricing to set contract terms and adjudicate claims is the Average Wholesale Price, called AWP.

The Predictive Acquisition Cost, called PAC, uses predictive analytics to consider various factors when estimating acquisition cost of a drug, such as maximum allowable cost benchmarks, published price lists, existing price benchmarks, drug dispensation metrics, supply-demand measures, and survey-based acquisition costs, according to the companies.

Elsevier will include PAC in its Gold Standard Drug Database product and price file, and also offer it as a stand-alone module.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access